SYN - Synthetic Biologics, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development11,84418,78429,10932,906
Selling General and Administrative5,7277,46710,1438,074
Non Recurring----
Total Operating Expenses17,57126,25139,25240,980
Operating Income or Loss-17,571-26,251-39,252-40,980
Income from Continuing Operations
Total Other Income/Expenses Net4,15010,75911,449-3,805
Earnings Before Interest and Taxes-17,571-26,251-39,252-40,980
Interest Expense----
Income Before Tax-13,421-15,492-27,803-44,785
Income Tax Expense----
Minority Interest-2,909-1,914-1,596-1,048
Net Income From Continuing Ops-13,421-15,492-27,803-44,785
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-13,367-15,174-27,255-43,737
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-25,291-22,136-27,255-43,737